Preprint Article Version 1 This version is not peer-reviewed

Design, Synthesis, and Evaluation of Oleyl-WRH Peptides for siRNA Delivery

Version 1 : Received: 10 July 2024 / Approved: 10 July 2024 / Online: 10 July 2024 (10:51:00 CEST)

How to cite: Rai, M. S.; Sajid, M. I.; Moreno, J.; Parang, K.; Tiwari, R. K. Design, Synthesis, and Evaluation of Oleyl-WRH Peptides for siRNA Delivery. Preprints 2024, 2024070833. https://doi.org/10.20944/preprints202407.0833.v1 Rai, M. S.; Sajid, M. I.; Moreno, J.; Parang, K.; Tiwari, R. K. Design, Synthesis, and Evaluation of Oleyl-WRH Peptides for siRNA Delivery. Preprints 2024, 2024070833. https://doi.org/10.20944/preprints202407.0833.v1

Abstract

Delivering nucleic acid therapeutics across cell membranes is a significant challenge. Cell-penetrating peptides (CPPs) containing arginine (R), tryptophan (W), and histidine (H) show promise for siRNA delivery. To improve siRNA delivery and silencing a model STAT3 gene, we hypothesized that oleyl acylation to CPPs, specifically (WRH)n, would enhance STAT3 silencing efficiency in breast and ovarian cancer cells. Using Fmoc/tBu solid-phase peptide chemistry, we synthesized, purified, and characterized the oleyl-conjugated (WRH)n (n = 1-4) peptides. The peptide:siRNA complexes were non-cytotoxic at N/P 40 (~20 μM) against MDA-MB-231, MCF-7, SK-OV-3, and HEK-293 cells after 72 h incubation. All peptide:siRNA complexes showed serum stability at N/P ≥40. The synthesized conjugates, with a diameter of <100 nm, formed nano complexes with siRNA and exhibited stable range of zeta potential values (13-18 mV at N/P 40). Confocal microscopy and flow cytometry analysis provided qualitative and quantitative evidence of successful cellular internalization of siRNA. Peptides oleyl-(WRH)3 and oleyl-(WRH)4 showed ~60% and ~75% cellular uptake of siRNA, respectively, in both MDA-MB-231 and SK-OV-3 cells. Western blot analysis of oleyl-(WRH)4 demonstrated effective silencing of the STAT-3 gene, with ~75% silencing in MDA-MB-231 cells and ~45% in SK-OV-3 cells.

Keywords

acylation; arginine; breast cancer; cell-penetrating peptide; histidine; MDA-MB-231; oleic acid; RNA interference; siRNA; SK-OV-3; STAT-3; tryptophan; western blotting

Subject

Medicine and Pharmacology, Oncology and Oncogenics

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.